Key words: reduction, 3,9-dihydropyrrolo[2,1-b]quinazolin-1(2H)-one, quinazolyl-2-propionic acid, 3-[(E)-arylmethylidene]-3,9-dihydropyrrolo[2,1-b]quinazolin-1(2H)-one, 3-[(E)-arylmethylidene]-1,2,3,9-tetrahydropyrrolo[2,1-b] quinazolin-1-ol, 3-[(E)-arylmethylidene]-3,9-dihydropyrrolo[2,1-b]quinazoline. 2 J = 18.0 3 J = 4.4; 2.80, dm 2 J = 18.0 3.24, dd 2 J = 17.6 3 J = 6.4; 2.76, dm 2 J = 17.6 3.25, dd 2 J = 17.6 3 J = 5.5; 2.75, dm 2 J = 17.6 3.31, dd 2 J = 18.0 3 J = 6.0; 2.80, dm 2 J = 18.0
547.856.1+547.75Quinazolyl-2-propionic acid hydrochloride (5) was synthesized by reduction of N-(o-nitrobenzyl)succinimide with tin chloride. A pyrroloquinazolin-1-one {4, 3,9-dihydropyrrolo[2,1-b]quinazolin-1(2H)-one} was prepared in 68% yield by heating 5 in Ac 2 O and subsequent treatment with Et 3 N. Compound 4 was obtained in 71% yield in one step by reduction of N-(o-nitrobenzyl)succinimide with Fe in the presence of HCl. Compound 4 was protonated, alkylated, and acylated on the N (4) atom. Derivatives of quinazolyl-2-propionic acid and 1-(2-aminobenzyl)succinimide were prepared by reaction of derivatives of 4 with nucleophilic reagents.Key words: alkylation, acylation, 3,9-dihydropyrrolo[2,1-b]quinazolin-1(2H)-one, quinazolyl-2-propionic acid, 1-(2-aminobenzyl)succinimide.The search for new synthetic pathways and the study of the properties of pyrrolo[2,1-b]quinazoline derivatives have recently acquired increasing importance. 1,2,3,9-Tetrahydro-and 9-oxo-dihydro derivatives of this heterocyclic system [peganine (1a), deoxypeganine (1b), vasicinone (2a), and deoxyvasicinone (2b)] are the principal alkaloids of Peganum harmala and P. nigellastrum and possess distinct cholinotropic activity [1,2]. For this reason, they have been used pharmacologically to treat various types of dependency (nicotine, alcohol, drug) and the depressive states, Alheizmer disease, and respiratory malfunctions associated with them [3][4][5][6][7].Other derivatives of pyrrolo[2,1-b]quinazoline are also known. These include 2,3-dihydropyrrolo[2,1-b]quinazolin-1,9-dione (3) [8-11] and 3,9-dihydropyrrolo[2,1-b]quinazolin-1(2H)-one (deoxypegan-1-one, 4), which was prepared for the first time by Gabriel at the beginning of the last century [12]. However, the properties of 3 and 4 have practically not been studied because of their scarcity. Currently known chemical transformations of 4 include only reduction [12][13][14][15] and opening of the pyrrole ring upon reaction with nucleophiles [12][13][14]. The only reactions with electrophiles are formation of the protonated salts 4·HI and 4·H 2 SnCl 6 [12] and the picrate [14].
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.